Paradromics has 2 close competitors: Neuralink, Neurable.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
Paradromics
Neuralink
NeurableBrain-computer interface company developing high data-rate BCI technology to provide solutions for people with neurological conditions.
Paradromics competes with 2 companies here: Neuralink, Neurable.
Paradromics was last valued at $500M . That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The closest neurotec peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Yes. Paradromics is a publicly traded company.
The last valuation is $500M.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
